Associated Papers
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D et al.
Hemasphere, 2020
Identification of HPV integration and gene mutation in HeLa cell line by integrated analysis of RNA-Seq and MS/MS data.
Sun H et al.
Journal of Proteome Research, 2015
Does CALU SNP rs1043550 contribute variability to therapeutic warfarin dosing requirements?
Glurich I et al.
Clinical Medicine & Research, 2013
Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms.
Daly AK
Archives of Toxicology, 2013
Effects of CYP4F2 gene polymorphisms on warfarin clearance and sensitivity in Korean patients with mechanical cardiac valves.
Lee KE et al.
Therapeutic Drug Monitoring, 2012
Evaluation of the warfarin-resistance polymorphism, VKORC1 Asp36Tyr, and its effect on dosage algorithms in a genetically heterogeneous anticoagulant clinic.
Shuen AY et al.
Clinical Biochemistry, 2012
Application of Akaike information criterion to evaluate warfarin dosing algorithm.
Harada T et al.
Thrombosis Research, 2010
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population.
Lubitz SA et al.
Journal of Thrombosis and Haemostasis : Jth, 2010
Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.
D'Andrea G et al.
Blood Reviews, 2008
Gamma-glutamyl carboxylase R325Q polymorphism on the response of acenocoumarol.
González-Conejero R et al.
Thrombosis Research, 2008
The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol.
González-Conejero R et al.
Journal of Thrombosis and Haemostasis : Jth, 2007
Association of warfarin dose with genes involved in its action and metabolism.
Wadelius M et al.
Human Genetics, 2007
Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
Kimura R et al.
Thrombosis Research, 2007
Pharmacogenetics of target genes across the warfarin pharmacological pathway.
Lal S et al.
Clinical Pharmacokinetics, 2006
Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients.
Rojo M et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 0